Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nakul Gupta

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
The Lancet. Gastroenterology & Hepatology|March 18, 2018
Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-seriesKeri E Lunsford, Milind Javle, Kirk Heyne, et al.
Science Translational Medicine|December 15, 2021
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancerAndrew W Chung, Kartik Anand, Ann C Anselme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2022
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast CancerKai Sun, Yitian Xu, Licheng Zhang, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
The Lancet. Gastroenterology & Hepatology|March 18, 2018
Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-seriesKeri E Lunsford, Milind Javle, Kirk Heyne, et al.
Science Translational Medicine|December 15, 2021
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancerAndrew W Chung, Kartik Anand, Ann C Anselme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2022
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast CancerKai Sun, Yitian Xu, Licheng Zhang, et al.
Pageof 4